Article

Statins: have we found the Holy Grail?

University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland.
Schweizerische medizinische Wochenschrift (impact factor: 1.68). 01/2012; 142:w13515. DOI:10.4414/smw.2012.13515 pp.w13515
Source: PubMed

ABSTRACT In coronary artery disease, cardiovascular risk factors are the main targets for primary and secondary prevention. Statins prevent cardiovascular events in patients at risk. However, despite the proven efficacy and safety of statins, relevant side effects exist and should be considered when treating patients.

0 0
 · 
0 Bookmarks
 · 
42 Views

Full-text

View
0 Downloads
Available from

Keywords

cardiovascular events
 
cardiovascular risk factors
 
coronary artery disease
 
main targets
 
proven efficacy
 
relevant side effects
 
secondary prevention